{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:33:42Z","timestamp":1788111222655,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/21801-2"],"award-info":[{"award-number":["2017\/21801-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/05320-0"],"award-info":[{"award-number":["2021\/05320-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/25247-5"],"award-info":[{"award-number":["2019\/25247-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303405\/2018-0"],"award-info":[{"award-number":["303405\/2018-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s43440-024-00614-4","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T21:01:47Z","timestamp":1718917307000},"page":"838-850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["\u03b2-Carboline derivatives are potent against Acute Myeloid Leukemia in vitro and in vivo"],"prefix":"10.1007","volume":"76","author":[{"given":"Maura Lima Pereira","family":"Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Foglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Bar\u00e9a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Rufino","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Sarragiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T. Olalla","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Marconi","family":"Roversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,20]]},"reference":[{"key":"614_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12943-016-0571-x","volume":"16","author":"KS Siveen","year":"2017","unstructured":"Siveen KS, Uddin S, Mohammad RM. Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Cancer. 2017;16:13. https:\/\/doi.org\/10.1186\/s12943-016-0571-x.","journal-title":"Mol Cancer"},{"key":"614_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","volume":"9","author":"L Falzone","year":"2018","unstructured":"Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9:1300. https:\/\/doi.org\/10.3389\/fphar.2018.01300.","journal-title":"Front Pharmacol"},{"key":"614_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/1871520614666141128121812","volume":"15","author":"M Zhang","year":"2015","unstructured":"Zhang M, Sun D. Recent advances of natural and synthetic \u03b2-carbolines as anticancer agents. Anticancer Agents Med Chem. 2015;15:537\u201347. https:\/\/doi.org\/10.2174\/1871520614666141128121812.","journal-title":"Anticancer Agents Med Chem"},{"key":"614_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113321","volume":"216","author":"S Aaghaz","year":"2021","unstructured":"Aaghaz S, Sharma K, Jain R, Kamal A. \u03b2-Carbolines as potential anticancer agents. Eur J Med Chem. 2021;216: 113321. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113321.","journal-title":"Eur J Med Chem"},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1039\/b712092n","volume":"3","author":"J Wu","year":"2007","unstructured":"Wu J, Cui G, Zhao M, Cui C, Peng S. Novel N-(3-carboxyl-9-benzyl-carboline-1-yl)ethylamino acids: synthesis, anti-proliferation activity and two-step-course of intercalation with calf thymus DNA. Mol Biosyst. 2007;3:855\u201361. https:\/\/doi.org\/10.1039\/b712092n.","journal-title":"Mol Biosyst"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0960-894x(02)00094-x","volume":"12","author":"Y Song","year":"2002","unstructured":"Song Y, Wang J, Teng SF, Kesuma D, Deng Y, Duan J, et al. Beta-carbolines as specific inhibitors of cyclin-dependent kinases. Bioorg Med Chem Lett. 2002;12:1129\u201332. https:\/\/doi.org\/10.1016\/s0960-894x(02)00094-x.","journal-title":"Bioorg Med Chem Lett"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.bmcl.2012.01.028","volume":"22","author":"GD Cuny","year":"2012","unstructured":"Cuny GD, Ulyanova NP, Patnaik D, Liu JF, Lin X, Auerbach K, et al. Structure-activity relationship study of beta-carboline derivatives as haspin kinase inhibitors. Bioorg Med Chem Lett. 2012;22:2015\u20139. https:\/\/doi.org\/10.1016\/j.bmcl.2012.01.028.","journal-title":"Bioorg Med Chem Lett"},{"key":"614_CR8","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/jm301788a","volume":"56","author":"R Chaniyara","year":"2013","unstructured":"Chaniyara R, Tala S, Chen CW, Zang X, Kakadiya R, Lin LF, et al. Novel antitumor indolizino[6,7-b]indoles with multiple modes of action: DNA cross-linking and topoisomerase I and II inhibition. J Med Chem. 2013;56:1544\u201363. https:\/\/doi.org\/10.1021\/jm301788a.","journal-title":"J Med Chem"},{"key":"614_CR9","doi-asserted-by":"publisher","first-page":"9154","DOI":"10.1021\/acs.jmedchem.9b02047","volume":"63","author":"X Lu","year":"2020","unstructured":"Lu X, Liu YC, Orvig C, Liang H, Chen ZF. Discovery of a copper-based Mcl-1 inhibitor as an effective antitumor agent. J Med Chem. 2020;63:9154\u201367. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02047.","journal-title":"J Med Chem"},{"key":"614_CR10","doi-asserted-by":"publisher","first-page":"9621","DOI":"10.18632\/aging.103232","volume":"12","author":"D Wang","year":"2020","unstructured":"Wang D, Nie Z, Jiang X, Ye J, Wei Z, Cheng D, et al. Pyrrolo [3,4-. Aging (Albany NY). 2020;12:9621\u201332. https:\/\/doi.org\/10.18632\/aging.103232.","journal-title":"Aging (Albany NY)"},{"key":"614_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejmech.2019.05.085","volume":"179","author":"MR Panice","year":"2019","unstructured":"Panice MR, Lopes SMM, Figueiredo MC, Goes Ruiz ALT, Foglio MA, Nazari Formagio AS, et al. New 3-tetrazolyl-\u03b2-carbolines and \u03b2-carboline-3-carboxylates with anti-cancer activity. Eur J Med Chem. 2019;179:123\u201332. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.085.","journal-title":"Eur J Med Chem"},{"key":"614_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12288-016-0770-z","volume":"33","author":"A Oodi","year":"2017","unstructured":"Oodi A, Norouzi H, Amirizadeh N, Nikougoftar M, Vafaie Z. Harmine, a novel DNA methyltransferase 1 inhibitor in the leukemia cell line. Indian J Hematol Blood Transfus. 2017;33:509\u201315. https:\/\/doi.org\/10.1007\/s12288-016-0770-z.","journal-title":"Indian J Hematol Blood Transfus"},{"key":"614_CR13","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.3390\/molecules17056100","volume":"17","author":"FC Savariz","year":"2012","unstructured":"Savariz FC, Foglio MA, de Carvalho JE, Ruiz AL, Duarte MC, da Rosa MF, et al. Synthesis and evaluation of new \u03b2-carboline-3-(4-benzylidene)-4H-oxazol-5-one derivatives as antitumor agents. Molecules. 2012;17:6100\u201313. https:\/\/doi.org\/10.3390\/molecules17056100.","journal-title":"Molecules"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.bmc.2014.10.031","volume":"22","author":"FC Savariz","year":"2014","unstructured":"Savariz FC, Foglio MA, Ruiz AL, da Costa WF, Silva MM, Santos JC, et al. Synthesis and antitumor activity of novel 1-substituted phenyl 3-(2-oxo-1,3,4-oxadiazol-5-yl) \u03b2-carbolines and their Mannich bases. Bioorg Med Chem. 2014;22:6867\u201375. https:\/\/doi.org\/10.1016\/j.bmc.2014.10.031.","journal-title":"Bioorg Med Chem"},{"key":"614_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.ejmech.2016.10.018","volume":"124","author":"VA Barbosa","year":"2016","unstructured":"Barbosa VA, Bar\u00e9a P, Mazia RS, Ueda-Nakamura T, Costa WFD, Foglio MA, et al. Synthesis and evaluation of novel hybrids \u03b2-carboline-4-thiazolidinones as potential antitumor and antiviral agents. Eur J Med Chem. 2016;124:1093\u2013104. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.018.","journal-title":"Eur J Med Chem"},{"key":"614_CR16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00262-021-03111-2","volume":"71","author":"FM Roversi","year":"2022","unstructured":"Roversi FM, Bueno MLP, da Silva JAF, Assis-Mendon\u00e7a GR, Torello CO, Shiraishi RN, et al. Novel inhibitor of hematopoietic cell kinase as a potential therapeutic agent for acute myeloid leukemia. Cancer Immunol Immunother. 2022;71:1909\u201321. https:\/\/doi.org\/10.1007\/s00262-021-03111-2.","journal-title":"Cancer Immunol Immunother"},{"key":"614_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbadis.2016.11.013","volume":"1863","author":"FM Roversi","year":"2017","unstructured":"Roversi FM, Pericole FV, Machado-Neto JA, da Silva Santos Duarte A, Longhini AL, Corrocher FA, et al. Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin\/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin\/PI3K pathway. Biochim Biophys Acta Mol Basis Dis. 2017;1863:450\u201361. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.013.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"614_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.634044","volume":"9","author":"FM Roversi","year":"2021","unstructured":"Roversi FM, Bueno MLP, Pericole FV, Saad STO. Hematopoietic Cell Kinase (HCK) is a player of the crosstalk between hematopoietic cells and bone marrow niche through CXCL12\/CXCR4 axis. Front Cell Dev Biol. 2021;9: 634044. https:\/\/doi.org\/10.3389\/fcell.2021.634044.","journal-title":"Front Cell Dev Biol"},{"key":"614_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/S12079-023-00773-8","author":"MLP Bueno","year":"2023","unstructured":"Bueno MLP, Saad STO, Roversi FM. The antitumor effects of WNT5A against hematological malignancies. J Cell Commun Signal. 2023. https:\/\/doi.org\/10.1007\/S12079-023-00773-8.","journal-title":"J Cell Commun Signal"},{"key":"614_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2019.00016","volume":"9","author":"FV Pericole","year":"2019","unstructured":"Pericole FV, Lazarini M, De Paiva LB, Da Silva Santos Duarte A, Ferro KPV, Niemann FS, et al. BRD4 inhibition enhances azacitidine efficacy in acute myeloid leukemia and myelodysplastic syndromes. Front Oncol. 2019;9:1\u201311. https:\/\/doi.org\/10.3389\/fonc.2019.00016.","journal-title":"Front Oncol"},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/jcmm.14066","volume":"23","author":"FM Roversi","year":"2019","unstructured":"Roversi FM, Cury NM, Lopes MR, Ferro KP, Machado-Neto JA, Alvarez MC, et al. Up-regulation of SPINT2\/HAI-2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion. J Cell Mol Med. 2019;23:1562\u201371. https:\/\/doi.org\/10.1111\/jcmm.14066.","journal-title":"J Cell Mol Med"},{"key":"614_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236003","author":"JR Sillar","year":"2019","unstructured":"Sillar JR, Germon ZP, DeIuliis GN, Dun MD. The role of reactive oxygen species in acute myeloid leukaemia. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20236003.","journal-title":"Int J Mol Sci"},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/10715761003667554","volume":"44","author":"GY Liou","year":"2010","unstructured":"Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479\u201396. https:\/\/doi.org\/10.3109\/10715761003667554.","journal-title":"Free Radic Res"},{"key":"614_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102043","volume":"88","author":"L Mele","year":"2020","unstructured":"Mele L, Del Vecchio V, Liccardo D, Prisco C, Schwerdtfeger M, Robinson N, et al. The role of autophagy in resistance to targeted therapies. Cancer Treat Rev. 2020;88: 102043. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102043.","journal-title":"Cancer Treat Rev"},{"key":"614_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2018.101084","volume":"25","author":"US Srinivas","year":"2019","unstructured":"Srinivas US, Tan BWQ, Vellayappan BA, Jeyasekharan AD. ROS and the DNA damage response in cancer. Redox Biol. 2019;25: 101084. https:\/\/doi.org\/10.1016\/j.redox.2018.101084.","journal-title":"Redox Biol"},{"key":"614_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37:266. https:\/\/doi.org\/10.1186\/s13046-018-0909-x.","journal-title":"J Exp Clin Cancer Res"},{"key":"614_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13046-014-0106-5","volume":"33","author":"UK Udensi","year":"2014","unstructured":"Udensi UK, Tchounwou PB. Dual effect of oxidative stress on leukemia cancer induction and treatment. J Exp Clin Cancer Res. 2014;33:106. https:\/\/doi.org\/10.1186\/s13046-014-0106-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"614_CR28","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4161\/auto.25399","volume":"9","author":"AD Garg","year":"2013","unstructured":"Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, et al. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy. 2013;9:1292\u2013307. https:\/\/doi.org\/10.4161\/auto.25399.","journal-title":"Autophagy"},{"key":"614_CR29","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.7150\/jca.54699","volume":"12","author":"R Huang","year":"2021","unstructured":"Huang R, Chen H, Liang J, Li Y, Yang J, Luo C, et al. Dual role of reactive oxygen species and their application in cancer therapy. J Cancer. 2021;12:5543\u201361. https:\/\/doi.org\/10.7150\/jca.54699.","journal-title":"J Cancer"},{"key":"614_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jhep.2012.01.027","volume":"57","author":"H Hikita","year":"2012","unstructured":"Hikita H, Kodama T, Shimizu S, Li W, Shigekawa M, Tanaka S, et al. Bak deficiency inhibits liver carcinogenesis: a causal link between apoptosis and carcinogenesis. J Hepatol. 2012;57:92\u2013100. https:\/\/doi.org\/10.1016\/j.jhep.2012.01.027.","journal-title":"J Hepatol"},{"key":"614_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4161\/auto.5338","volume":"4","author":"DJ Klionsky","year":"2008","unstructured":"Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008;4:151\u201375. https:\/\/doi.org\/10.4161\/auto.5338.","journal-title":"Autophagy"},{"key":"614_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13045-022-01262-y","volume":"15","author":"W Seo","year":"2022","unstructured":"Seo W, Silwal P, Song I-C, Jo E-K. The dual role of autophagy in acute myeloid leukemia. J Hematol Oncol. 2022;15:51. https:\/\/doi.org\/10.1186\/s13045-022-01262-y.","journal-title":"J Hematol Oncol"},{"key":"614_CR33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s43587-021-00098-4","volume":"1","author":"Y Aman","year":"2021","unstructured":"Aman Y, Schmauck-Medina T, Hansen M, Morimoto RI, Simon AK, Bjedov I, et al. Autophagy in healthy aging and disease. Nat Aging. 2021;1:634\u201350. https:\/\/doi.org\/10.1038\/s43587-021-00098-4.","journal-title":"Nat Aging"},{"key":"614_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101618","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11101618.","journal-title":"Cancers (Basel)"},{"key":"614_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020412","author":"VE Sanchez","year":"2019","unstructured":"Sanchez VE, Nichols C, Kim HN, Gang EJ, Kim YM. Targeting PI3K signaling in acute lymphoblastic leukemia. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20020412.","journal-title":"Int J Mol Sci"},{"key":"614_CR36","doi-asserted-by":"publisher","first-page":"23565","DOI":"10.1038\/s41598-021-03010-7","volume":"11","author":"J Kivioja","year":"2021","unstructured":"Kivioja J, Malani D, Kumar A, Kontro M, Parsons A, Kallioniemi O, et al. FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML. Sci Rep. 2021;11:23565. https:\/\/doi.org\/10.1038\/s41598-021-03010-7.","journal-title":"Sci Rep"},{"key":"614_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ijo.2020.5052","volume":"57","author":"M Vu","year":"2020","unstructured":"Vu M, Kassouf N, Ofili R, Lund T, Bell C, Appiah S. Doxorubicin selectively induces apoptosis through the inhibition of a novel isoform of Bcl-2 in acute myeloid leukaemia MOLM-13 cells with reduced Beclin 1 expression. Int J Oncol. 2020;57:113\u201321. https:\/\/doi.org\/10.3892\/ijo.2020.5052.","journal-title":"Int J Oncol"}],"updated-by":[{"DOI":"10.1007\/s43440-024-00655-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000}}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00614-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00614-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00614-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:04:59Z","timestamp":1728482699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00614-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,20]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00614-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s43440-024-00655-9","asserted-by":"object"}]},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,20]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s43440-024-00655-9","URL":"https:\/\/doi.org\/10.1007\/s43440-024-00655-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Our research adhered to ethical guidelines established by the Declaration of Helsinki and was approved by the Human Ethics Committee of the State University of Campinas (Certificates of Presentation for Ethical Review: CAAE: 45254321.7.0000.5404 and 1110.0.146.000-11). All patients provided written informed consent, and samples were collected at diagnosis. For animal studies, the protocol received approval from the Institutional Committee of Animal Care of the State University of Campinas (protocol number: 5956-1\/2022).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All patients provided written informed consent for the publication of anonymized information from this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics statements"}},{"value":"All authors have provided their consent to the publication of this manuscript. Ethical approval for this study was obtained from at the Hematology and Transfusion Medicine Center\/University of Campinas.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}